INNV - Innovus Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue8,816.34,818.603735.7171,030.113
Cost of Revenue1,848.3251,083.094340.713292.08
Gross Profit6,967.9753,735.509395.004738.033
Operating Expenses
Research Development38.81177.80477.804143.914
Selling General and Administrative12,028.3869,427.1173,910.1924,378.749
Non Recurring----
Others----
Total Operating Expenses13,915.52210,588.0154,250.9054,814.743
Operating Income or Loss-5,099.222-5,769.412-3,515.188-3,784.63
Income from Continuing Operations
Total Other Income/Expenses Net-1,401.666-7,929.342-1,444.468-1,042.337
Earnings Before Interest and Taxes-5,099.222-5,769.412-3,515.188-3,784.63
Interest Expense-872.166-6,661.694-1,153.376-532.23
Income Before Tax-6,500.888-13,698.754-4,959.656-4,826.967
Income Tax Expense3.22.4-757.028-
Minority Interest----
Net Income From Continuing Ops-6,504.088-13,701.154-4,202.628-4,826.967
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-6,504.088-13,701.154-4,202.628-4,826.967
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-6,504.088-13,701.154-4,202.628-4,826.967